NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its second quarter revenues rose 3 percent year over year, thanks almost entirely to a 4 percent increase in its clinical laboratory service revenues.

For the three months ended Jan. 31, the firm reported total revenues of $27.0 million, up from $26.3 million in Q2 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.